UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of ~~September~~October, 2024

Commission File Number: 001-36619

Affimed N.V.

Gottlieb-Daimler-Straße 2,

68165 Mannheim

Germany

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

AFFIMED N.V.

OnAnnual ~~September 11,~~General ~~2024,~~Meeting ~~Affimed~~Results ~~N.V. announced an extraordinary general meeting of shareholders to be held on October 10, 2024 and made available to its shareholders certain other materials in connection with such meeting.~~

~~Such~~On October 10, ~~materials~~2024, ~~are~~Affimed ~~attached~~N.V. as(“Affimed” ~~exhibits~~or tothe ~~this~~“Company”) ~~Form~~held ~~6-K~~an ~~and~~Extraordinary ~~are~~General ~~incorporated~~Meeting byof ~~reference~~the ~~herein~~shareholders. The final results of each of the agenda items submitted to a vote of the shareholders are as follows:

1Agenda item 2: Appointment of Mr. Shawn Leland as a managing director

Affimed shareholders approved the appointment of Mr. Shawn Leland as a managing director.

Agenda item 3: Approval of an addendum to the Remuneration Policy for the Management Board in respect of Mr. Shawn Leland

Affimed shareholders approved the addendum to the remuneration policy for the Company’s management board in respect of Mr. Shawn Leland.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AFFIMED N.V.
Date: September 11, 2024	By:	/s/ Andreas Harstrick
Date: October 15, 2024	By:	/s/ Shawn Leland
	Name:	~~Andreas~~Shawn ~~Harstrick~~Leland
	Title:	Chief ~~Medical~~Executive Officer
	By:	/s/ Denise Mueller
	Name:	Denise Mueller
	Title:	Chief Business Officer

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Notice convening the extraordinary general meeting of shareholders
99.2		Agenda including explanation
99.3		Powers of attorney

Filing Compare · Affimed N.V.